Andrew Craig Miller - Jun 10, 2021 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Operating Officer
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
Stock symbol
KRTX
Transactions as of
Jun 10, 2021
Transactions value $
-$3,546,153
Form type
4
Date filed
6/14/2021, 09:13 PM
Previous filing
May 12, 2021
Next filing
Aug 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $123K +13.3K +29.3% $9.20* 58.8K Jun 10, 2021 Direct
transaction KRTX Common Stock Sale -$1.65M -13.3K -22.66% $123.68 45.5K Jun 10, 2021 Direct F1
transaction KRTX Common Stock Options Exercise $76.7K +8.33K +18.31% $9.20* 53.8K Jun 11, 2021 Direct
transaction KRTX Common Stock Sale -$1.08M -8.33K -15.48% $129.33 45.5K Jun 11, 2021 Direct F1
transaction KRTX Common Stock Options Exercise $76.7K +8.33K +18.32% $9.20* 53.8K Jun 14, 2021 Direct
transaction KRTX Common Stock Sale -$1.1M -8.33K -15.48% $131.44 45.5K Jun 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -13.3K -4.44% $0.00 287K Jun 10, 2021 Common Stock 13.3K $9.20 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -8.33K -2.9% $0.00 279K Jun 11, 2021 Common Stock 8.33K $9.20 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -8.33K -2.99% $0.00 270K Jun 14, 2021 Common Stock 8.33K $9.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 This option vests and becomes exercisable in thirty equal monthly installments beginning on March 21, 2019.